Page 2 - முடிவு பயனர் மருந்து உயிரி தொழில்நுட்பவியல் நிறுவனங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from முடிவு பயனர் மருந்து உயிரி தொழில்நுட்பவியல் நிறுவனங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In முடிவு பயனர் மருந்து உயிரி தொழில்நுட்பவியல் நிறுவனங்கள் Today - Breaking & Trending Today

Proteomics Market worth $ 73.17 Billion, Globally, by 2028 at 16.50% CAGR: Verified Market Research™


Share this article
Share this article
Jersey City, N.J., June 9, 2021 /PRNewswire/ Verified Market Research recently published a report, Proteomics Market By Reagent (Protein Microarray Reagents, X – Ray Crystallography Reagents, Electrophoresis Reagents & Others), By Instrumentation Technology (X – Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation & Others), By Software and Service (Core Proteomics Services and Bioinformatics Software and Services), By Application (Clinical Diagnostics, Drug Discovery and Other Applications), and By Geography. According to Verified Market Research, the Global Proteomics Market was valued at USD 21.64 Billion in 2020 and is projected to reach USD 73.17 Billion by 2028, growing at a CAGR of 16.50% from 2021 to 2028. ....

United States , United Kingdom , Asia Pacific , Ray Crystallographysurface , Tao Xu , Edwyne Fernandes , Minerals Metals , Software Services , Biotechnological Companies , Semiconductor Electronics , Product Development , Fios Genomics Ltd , End User Pharmaceutical Biotechnology Companies , Ion Channel Assay Services , Technology Absorbance , Core Proteomics Services , National Institutes Of Health , Instrumentation Technology , Nuclear Receptor Assay Services Others , Drug Discovery Services Market , Thermo Fisher Scientific Inc , Bruker Corporation , Agilent Technologies Inc , University Of Copenhagen , Bioinformatics Software , Biotechnology Companies Research ,

Plasma Fractionation Market to Gain Massive Traction; USD 48.55 Billion at 7.6% CAGR by 2027; Constant Research and Study of immunoglobulin to Lighten Business Prospects, states Fortune Business Insights™


Share:
Pune, India, March 03, 2021 (GLOBE NEWSWIRE) The global
plasma fractionation market size is expected to reach USD 48.55 billion by 2027, exhibiting a CAGR of 7.6% during the forecast period. The growing incidence of immunological disorders is expected to spur demand for the market, states Fortune Business Insights, in a report, titled Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Immunoglobulin, Albumin, Coagulation Factors, Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics,  Clinical Research Laboratories, and Others), and Regional Forecast, 2020-2027. The market size stood at USD 25.44 billion in 2019.
Notable Development: ....

United States , United Kingdom , Diagnostics Research Laboratories , Age Group Pediatric , Research Methodology , Route Of Administration Parenteral , A Sample Copy Of The Research , Research Scope , Customized Research , Main Companies , Route Of Administration Injectable , Quick Buy Wearable Medical Devices Market Research , Clinical Research Laboratories , End User Pharmaceutical Biotechnology Companies , Fortune Business Insights , Fractionation Market Size , Coagulation Factors , Protease Inhibitors , Critical Care , Regional Forecast , Sample Copy , Research Report , Government Regulations , Propel Market , North America , Plasma Application ,